Estradiol dibutyrate: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 27: | Line 27: | ||
[[Category:Synthetic estrogens]] | [[Category:Synthetic estrogens]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Estradiol dibutyrate == | |||
<gallery> | |||
File:Estradiol dibutyrate.svg|Estradiol dibutyrate | |||
</gallery> | |||
Latest revision as of 20:46, 16 March 2025
Estradiol dibutyrate (EDB) is a synthetic, steroidal estrogen that is used in medicine. It is an ester of estradiol, a naturally occurring estrogen, and butyric acid, a short-chain fatty acid. EDB is used in hormone therapy for menopausal symptoms and in hormonal birth control.
Pharmacology[edit]
EDB acts as a prodrug to estradiol in the body. After administration, it is converted into estradiol by esterases. Estradiol is a potent estrogen and is responsible for the effects of EDB. It binds to and activates the estrogen receptor, a nuclear receptor that is expressed in many different tissues in the body.
Medical uses[edit]
EDB is used in hormone therapy for menopausal symptoms such as hot flashes, vaginal dryness, and osteoporosis. It is also used in hormonal birth control, in combination with a progestin. EDB has been used in the treatment of breast cancer, although it is not commonly used for this purpose today due to the availability of more effective treatments.
Side effects[edit]
The side effects of EDB are similar to those of other estrogens. They can include breast tenderness, nausea, bloating, and an increased risk of blood clots and stroke. Long-term use of EDB can increase the risk of endometrial cancer.
History[edit]
EDB was first synthesized in the 1950s. It was introduced for medical use in the 1960s.
Society and culture[edit]
EDB is marketed under a variety of brand names worldwide. It is available as an oral tablet, a transdermal patch, and a vaginal ring.
See also[edit]
Estradiol dibutyrate[edit]
-
Estradiol dibutyrate
